Kampanjeplan Propanc Biopharma, Inc.
Avansert tidsplan
Enkel graf
Om selskapet
Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. Flere detaljerЦена ао | 0.0027 |
---|---|
EBITDA | -0.0026 |
P/BV | -0.0014 |
EV/EBITDA | -0.6557 |
Число акций ао | 0.0017388 млрд |
Сайт | https://www.propanc.com |
Валюта | usd |
ISIN | US74346N4043 |
Sector | Health Care |
Industry | Biotechnology |
Валюта отчета | usd |
Prisendring per dag: | 0% (0.0004) |
---|---|
Prisendring per uke: | 0% (0.0004) |
Prisendring per måned: | 0% (0.0004) |
Prisendring over 3 måneder: | -55.56% (0.0009) |
Prisendring over seks måneder: | -63.64% (0.0011) |
Prisendring per år: | -97.95% (0.0195) |
Prisendring over 3 år: | -98.69% (0.0306) |
Prisendring over 5 år: | -99.96% (0.93) |
Prisendring siden begynnelsen av året: | -96.33% (0.0109) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Mr. James Nathanielsz | Executive Chairman, CEO, CFO, Treasurer & Secretary | 430.28k | 1974 (50 år) |
Dr. Julian Norman Kenyon ChB, M.D., MB | Chief Scientific Officer, CTO & Director | 35.99k | 1948 (76 år) |
Prof. Klaus Kutz | Chief Medical Officer & Member of Scientific Advisory Board | 18.23k |
Adresse: Australia, Camberwell. VIC, 302. 6 Butler Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.propanc.com
Nettsted: https://www.propanc.com